Lee Kalowski
CIK 1618273 · CFO and President · last filed 2026-07-20
Lee Kalowski is a CFO and President who has filed 30 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for QTTB, was dated Jul 20, 2026. Across all open-market trades the lifetime net is −$3.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.39M
3
30
-$3.05M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QTTB | CFO and President | 142,443 | $15.95 | $2.27M | -$57.1K | 7 | 2026-07-20 |
| BCYC | President and CFO | 30,309 | $4.00 | $121.2K | -$2.82M | 16 | 2023-04-05 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Chief Financial Officer | 4,550 | — | — | -$174.5K | 6 | 2015-12-17 |
Recent Filings
30 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-20 | QTTB | Grant (A) | +53,250 | $0 | EDGAR |
| 2026-03-20 | QTTB | Grant (A) | +53,250 | $0 | EDGAR |
| 2026-02-27 | QTTB | Sell (S) | −3,995 | -$18.0K | EDGAR |
| 2025-12-04 | QTTB | Sell (S) | −9,072 | -$31.4K | EDGAR |
| 2025-12-02 | QTTB | Notice (144) | −9,072 | -$31.4K | EDGAR |
| 2025-08-28 | QTTB | Sell (S) | −4,240 | -$7.6K | EDGAR |
| 2025-02-27 | QTTB | Mixed | +53,250 | $0 | EDGAR |
| 2024-03-27 | QTTB | Grant (A) | — | $0 | EDGAR |
| 2023-04-05 | BCYC | Sell (S) | −376 | -$7.9K | EDGAR |
| 2023-01-05 | BCYC | Mixed | +15,685 | -$52.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.